Karuna Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Karuna Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q4 2023.
  • Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $38.3M, a 64.4% increase year-over-year.
  • Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $74.6M, a 57.2% increase year-over-year.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $74.6M, a 57.2% increase from 2022.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $47.5M, a 59.2% increase from 2021.
  • Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.8M, a 121% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $74.6M $38.3M +$15M +64.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $59.6M $18.3M +$6.28M +52.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $53.3M $18M +$5.87M +48.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $47.5M $15.5K +$4.87K +45.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $47.5M $23.3M +$15M +180% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $32.5M $12M +$3.82M +46.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $28.7M $12.1M +$4.67M +62.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $24M $10.6K* -$5.81M -99.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $29.8M $8.32M +$3.85M +86.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $26M $8.2M +$4.06M +97.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $21.9M $7.47M +$4.24M +131% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $17.7M $5.82M +$4.19M +256% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $13.5M $4.47M +$3.49M +355% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $9.99M $4.14M +$2.5M +152% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $7.48M $3.23M -$3.62M -52.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $11.1M $1.63M -$1.47M -47.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $12.6M $981K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.64M +$1.24M +304% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.84M +$6.78M +10265% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $3.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 $406K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $66K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.